In which phase of clinical trials, post-marketing surveillance of a drug is carried out
**Core Concept**
Post-marketing surveillance of a drug involves the continuous monitoring of a medication's safety and efficacy after it has been approved for public use. This phase is crucial for detecting rare adverse effects or long-term consequences of drug use.
**Why the Correct Answer is Right**
The correct answer is **Phase IV**, also known as post-marketing surveillance or post-launch surveillance. During this phase, the drug is used by a large population, and its safety and efficacy are continuously monitored. This phase helps to identify any rare or long-term side effects that may not have been apparent during the earlier phases of clinical trials.
**Why Each Wrong Option is Incorrect**
**Option A:** Phase I trials involve the first administration of a new drug to a small group of healthy volunteers to assess its safety, tolerability, and pharmacokinetics. This phase is not related to post-marketing surveillance.
**Option B:** Phase II trials involve a larger group of patients to assess the efficacy and side effects of a new drug. While this phase is more extensive than Phase I, it does not involve post-marketing surveillance.
**Option C:** Phase III trials involve a large group of patients to confirm the efficacy and safety of a new drug compared to existing treatments. While Phase III trials are more extensive than Phase II, they do not involve post-marketing surveillance.
**Clinical Pearl / High-Yield Fact**
Post-marketing surveillance is essential for detecting rare adverse effects, which may not have been apparent during earlier phases of clinical trials. This phase helps to ensure that medications remain safe for public use.
**Correct Answer:** D. Phase IV.